A detailed history of Valley National Advisers Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Valley National Advisers Inc holds 5,362 shares of BMY stock, worth $315,660. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,362
Previous 7,654 29.95%
Holding current value
$315,660
Previous $317,000 12.62%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$39.66 - $51.75 $90,900 - $118,611
-2,292 Reduced 29.95%
5,362 $277,000
Q2 2024

Jul 18, 2024

SELL
$40.25 - $52.99 $63,876 - $84,095
-1,587 Reduced 17.17%
7,654 $317,000
Q1 2024

Apr 19, 2024

SELL
$47.98 - $54.4 $91,977 - $104,284
-1,917 Reduced 17.18%
9,241 $501,000
Q4 2023

Jan 25, 2024

SELL
$48.48 - $57.85 $110,098 - $131,377
-2,271 Reduced 16.91%
11,158 $572,000
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $11,172 - $12,492
193 Added 1.46%
13,429 $779,000
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $5,224 - $5,800
82 Added 0.62%
13,236 $847,000
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $30,423 - $34,507
-463 Reduced 3.4%
13,154 $928,000
Q4 2022

Jan 12, 2023

SELL
$68.48 - $81.09 $60,741 - $71,926
-887 Reduced 6.12%
13,617 $979,000
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $11 - $6,531
-85 Reduced 0.58%
14,504 $1.04 Million
Q2 2022

Jul 15, 2022

BUY
$72.62 - $79.98 $12,272 - $13,516
169 Added 1.17%
14,589 $1.1 Million
Q1 2022

May 06, 2022

BUY
$61.48 - $73.72 $68,119 - $81,681
1,108 Added 8.32%
14,420 $1.05 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $50,948 - $59,394
-950 Reduced 6.66%
13,312 $830,000
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $1,656 - $1,940
28 Added 0.2%
14,262 $844,000
Q2 2021

Aug 02, 2021

BUY
$61.91 - $67.42 $7,553 - $8,225
122 Added 0.86%
14,234 $951,000
Q1 2021

May 07, 2021

SELL
$59.34 - $66.74 $4,450 - $5,005
-75 Reduced 0.53%
14,112 $891,000
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $6,351 - $7,197
-110 Reduced 0.77%
14,187 $880,000
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $20,445 - $22,655
356 Added 2.55%
14,297 $861,000
Q2 2020

Aug 10, 2020

SELL
$54.82 - $64.09 $2,302 - $2,691
-42 Reduced 0.3%
13,941 $820,000
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $38,558 - $56,034
831 Added 6.32%
13,983 $779,000
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $410,559 - $535,537
8,343 Added 173.49%
13,152 $844,000
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $299 - $354
7 Added 0.15%
4,809 $244,000
Q2 2019

Aug 08, 2019

BUY
$44.62 - $49.34 $312 - $345
7 Added 0.15%
4,802 $218,000
Q1 2019

Apr 26, 2019

BUY
$45.12 - $53.8 $315 - $376
7 Added 0.15%
4,795 $229,000
Q4 2018

Feb 25, 2019

BUY
$48.76 - $63.23 $1,804 - $2,339
37 Added 0.78%
4,788 $249,000
Q3 2018

Nov 08, 2018

BUY
$55.19 - $62.25 $9,934 - $11,205
180 Added 3.94%
4,751 $295,000
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $151 - $188
-3 Reduced 0.07%
4,571 $253,000
Q1 2018

Apr 19, 2018

BUY
$59.92 - $68.98 $299 - $344
5 Added 0.11%
4,574 $289,000
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $35,724 - $38,948
-596 Reduced 11.54%
4,569 $280,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $285,262 - $329,217
5,165
5,165 $329,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.